You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香雪製藥(300147.SZ)擬223.13萬元轉讓納泰生物4.1667%股權予蘇州聖諾
格隆匯 01-25 20:08

格隆匯 1 月 25日丨香雪製藥(300147.SZ)公佈,公司基於業務發展佈局的考慮,將公司持有的廣州納泰生物醫藥技術有限公司(“納泰生物”)4.1667%股權,以人民幣約223.13萬元的價格轉讓給蘇州聖諾生物醫藥技術有限公司(“蘇州聖諾”),雙方簽署了《股權轉讓協議》。

公司根據業務發展規劃和實際經營需要轉讓納泰生物的股權,有利於公司聚焦主營業務的發展,進一步完善了公司的管理體系與股權架構;有利於實現投資收益,調整和優化公司資產結構;股權轉讓對價按照公司出資金額及出資時間,每年10%收益計算,此次交易可回籠前期已投入的資金,也為公司帶來一定的收益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account